Overview

A Study to Assess the Bioequivalence Between Brivaracetam Tablet and Dry Syrup in Healthy Japanese Male Study Participants

Status:
COMPLETED
Trial end date:
2024-06-04
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate the bioequivalence between the BRV tablet and BRV dry syrup after multiple oral doses in healthy male Japanese participants.
Phase:
PHASE1
Details
Lead Sponsor:
UCB Biopharma SRL
Treatments:
brivaracetam